A Conversation Between Ignasi Carrió and Ken Herrmann
J Nucl Med
.
2020 May;61(5):638-640.
doi: 10.2967/jnumed.120.245795.
Authors
Ignasi Carrió
1
,
Ken Herrmann
2
Affiliations
1
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; and.
2
Universitätsklinikum Essen, Essen, Germany.
PMID:
32358175
DOI:
10.2967/jnumed.120.245795
No abstract available
MeSH terms
Clinical Trials as Topic
Humans
Nuclear Medicine*
Radiopharmaceuticals
Substances
Radiopharmaceuticals